Thrombin activatable fibrinolysis inhibitor and hemostatic changes in patients with type I diabetes mellitus with and without microvascular complications

2003 ◽  
Vol 14 (6) ◽  
pp. 551-556 ◽  
Author(s):  
Jovan P Antovic ◽  
Marianne Yngen ◽  
Claes-Göran Östenson ◽  
Aleksandra Antovic ◽  
Håkan N Wallen ◽  
...  
Diabetes ◽  
1984 ◽  
Vol 33 (4) ◽  
pp. 394-400 ◽  
Author(s):  
G. Bolli ◽  
P. De Feo ◽  
S. De Cosmo ◽  
G. Perriello ◽  
G. Angeletti ◽  
...  

Diabetes ◽  
1987 ◽  
Vol 36 (11) ◽  
pp. 1286-1291 ◽  
Author(s):  
P. Vardi ◽  
S. A. Dib ◽  
M. Tuttleman ◽  
J. E. Connelly ◽  
M. Grinbergs ◽  
...  

Diabetes ◽  
1990 ◽  
Vol 39 (3) ◽  
pp. 369-375 ◽  
Author(s):  
M. M. Landgraf-Leurs ◽  
C. Drummer ◽  
H. Froschl ◽  
R. Steinhuber ◽  
C. Von Schacky ◽  
...  

Diabetes ◽  
1984 ◽  
Vol 33 (6) ◽  
pp. 516-521 ◽  
Author(s):  
O. P. Ganda ◽  
S. Srikanta ◽  
S. J. Brink ◽  
M. A. Morris ◽  
R. E. Gleason ◽  
...  

2002 ◽  
Vol 87 (12) ◽  
pp. 5507-5515 ◽  
Author(s):  
Juan Carlos López-Alvarenga ◽  
Teresa Zariñán ◽  
Aleida Olivares ◽  
Jorge González-Barranco ◽  
Johannes D. Veldhuis ◽  
...  

Diabetes Care ◽  
1983 ◽  
Vol 6 (3) ◽  
pp. 251-255 ◽  
Author(s):  
E. N. Ellis ◽  
B. H. Brouhard ◽  
L. Lagrone ◽  
L. B. Travis

Sign in / Sign up

Export Citation Format

Share Document